In an operational review, BHP Billiton (LSE: BLT) says it increased production by 9% for the nine months ended March 2015. The firm reckons its on track to deliver production growth of 16% over two years by the end of this year.
Theres a similar story at Rio Tinto (LSE: RIO). The firms recent first-quarter update revealed increased commodity production across most of the resources the company extracts.
Does rising production make these firms attractive to investors now, though? I dont think it does.
The chiefs think its a good thing
BHP Billitons chief executive reckons the firms strong operating performance, improved productivity and lower costs helps mitigate the impact of subdued commodity prices and thus supports returns for the companys shareholders.
Rio Tintos chief executive says a drive for efficiency in all aspects of Rios business reflects in a solid production performance. By making best use of high-quality assets, a low cost base, and the firms operating and commercial capability, Rio hopes to protect profit margins in the face of declining commodity-selling prices, which the company reckons will maximise returns for shareholders throughout the cycle.
I can see the logic, and the necessity of their positioning on the issue, however whats essential for Rio Tintos and BHP Billitons financial survival now doesnt automatically equate to those firms making good candidates for an investment in their shares at the moment. In fact, I think an investment now has a 50/50 chance of winning or losing in the short- to medium-termthey are not investing odds, they are gambling odds.
We must look at the big commodity producing companies as cyclical firms before anything else. Its easy to allow a big dividend payout to seduce us, for example, but the investing outcome in the long run depends on what commodity prices do.
BHP Billiton and Rio Tinto produce resources for which they have very little control over output selling prices. The control they do have mostly amounts to either producing or not producing. Right now, commodity prices have fallen from what they were not so long ago. In reaction, both firms chose to increase production to maintain marginsthey are earning less for their labours so now work longer to keep up the level of take-home pay.
However, the sums wont add up if commodity prices fall further from here. If you think that cant happen, think of the price of oil few foresaw that falling by more than 50% as it did recently. We dont need to have very long memories to remember most commodity prices in the doldrums either 20 years or so? Back then, we had to pay the scrap man to come and collect our old bangers, which meant fly dumping and roadside car burning became rife, making the countryside and urban back alleyways look like a war zone.
Supply and demand
Paradoxically, the supply and demand equation dictates that prices rise when either excess demand or under supply are present. Oil is low right now because of over-supply. BHP Billiton and Rio Tinto need prices to rise in order to make larger profits but both are charging towards ramping up production. Perhaps they both see escalating demand on the horizon? Maybe, but I think buying shares in highly cyclical firms such as these is too difficult to get right mid-macro-economic cycle such as now.
I want to see their share prices on the ground and trodden in before Ill even consider a speculative punt on catching the next up-leg. They can keep their fat dividends. A 50% or so share-price decline could wipe out any gain from dividends just like that anyway. Can you imagine that happening from here? I certainly can.
BHP Billiton and Rio Tinto do not top my list of attractive dividend candidates, as you may gather. Investing to harvest dividends is not the simple stock market solution it might appear to be. Success in dividend investing features in a particular wealth report produced by our analysts at the Motley Fool. It’s a solid read and helps guide past some of the hard-to-spot pitfalls of the game. There’s a copy with your name on it if you click here.
A Bigger Piece Of A 4 Billion Pie?
This fast-growing pharmaceutical business could be all set to become a potential blockbuster.
Recent approvals in Europe and Japan of its latest niche drug means it can now tap a market worth an estimated 4bn a year potentially doubling its sales in the process.
Thats just one of the reasons why our Motley Fool analysts think this under-the-radar innovator could be among the big winners of tomorrow.
To find out more, click here to download this FREE small-cap report now
Kevin Godbold has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. We Fools don’t all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.